Tubeless automated insulin delivery system improves blood glucose outcomes

People with type 1 diabetes can improve their blood sugar control while reducing time with low blood sugar, or hypoglycemia, using Insulet Corporation’s Omnipod 5 Automated Insulin Delivery System compared to their standard insulin therapy. Results from an industry-sponsored study of the latest Omnipod, the first tubeless, wearable insulin pump, will be presented at ENDO 2021, the Endocrine Society’s annual meeting.

AADE and AANP Partner to Increase Adoption of Professional Continuous Glucose Monitoring Programs

The American Association of Diabetes Educators (AADE) and the American Association of Nurse Practitioners (AANP) have partnered to release a new tool kit that guides healthcare professionals in the implementation of a professional continuous glucose monitoring (CGM) program within their health systems.